Review of Myopia Management

Pharmaceutical Interventions

362

What’s New with Pharmaceutical Interventions for Myopia

Presently, only atropine, pirenzepine, and 7-methylxanthine are shown to reduce myopia progression in human trials.
574

Low-Concentration Atropine for Myopia Progression (LAMP)

A summary of the LAMP Study results
Atropine – Wonder or Weak Treatment?

Atropine has been the apparent hero of myopia management since the 2006 publication of the ATOM (atropine for the treatment of childhood...

More Posts

To Top

Subscribe Today Free...

And join more than 25,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.

YOUR EMAIL

FIRST NAME

LAST NAME

Subscribe Today Free...

And join more than 25,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.

YOUR EMAIL

FIRST NAME

LAST NAME

Subscribe Today for Free...

Join more than 56,000 of your American & international MD & OD colleagues who have made Review of Myopia Management a key educational resource in the global fight to manage the growing prevalence of myopia.

Subscribe Today for Free...

Join more than 56,000 of your American & international MD & OD colleagues who have made Review of Myopia Management a key educational resource in the global fight to manage the growing prevalence of myopia.